NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $41,000 | -22.6% | 77,624 | 0.0% | 0.20% | -26.4% |
| Q2 2020 | $53,000 | -23.2% | 77,624 | -15.4% | 0.26% | -38.9% |
| Q1 2020 | $69,000 | -73.2% | 91,700 | -46.2% | 0.43% | -43.3% |
| Q4 2019 | $257,000 | -15.7% | 170,294 | -17.3% | 0.77% | +63.3% |
| Q3 2019 | $305,000 | +14.7% | 206,000 | 0.0% | 0.47% | +31.7% |
| Q2 2019 | $266,000 | -50.6% | 206,000 | 0.0% | 0.36% | -40.0% |
| Q1 2019 | $538,000 | +15.9% | 206,000 | -26.7% | 0.59% | +34.8% |
| Q4 2018 | $464,000 | -67.6% | 281,000 | -4.7% | 0.44% | -53.8% |
| Q3 2018 | $1,431,000 | -22.4% | 295,000 | 0.0% | 0.95% | -12.9% |
| Q2 2018 | $1,844,000 | +1.0% | 295,000 | +34.1% | 1.09% | +9.4% |
| Q1 2018 | $1,826,000 | -12.7% | 220,000 | +7.3% | 1.00% | -17.4% |
| Q4 2017 | $2,091,000 | – | 205,000 | – | 1.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,858,889 | $7,337,000 | 5.11% |
| Proxima Capital Management, LLC | 170,294 | $257,000 | 0.77% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,530,731 | $5,331,000 | 0.44% |
| Nantahala Capital Management | 4,610,000 | $6,961,000 | 0.21% |
| Wealthstar Advisors, LLC | 73,295 | $111,000 | 0.07% |
| Alambic Investment Management, L.P. | 51,733 | $78,000 | 0.06% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $151,000 | 0.05% |
| BCS Wealth Management | 29,520 | $45,000 | 0.03% |
| Allred Capital Management, LLC | 24,995 | $37,742,000 | 0.02% |
| ALGERT GLOBAL LLC | 34,254 | $52,000 | 0.02% |